LTZ Therapeutics

United States · Biotech · Healthtech · AI

LTZ Therapeutics develops cancer immunotherapies that target myeloid biology.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed$38MGL Ventures — Role not disclosed
Sourcesprojectstartups.com ↗